Authors: Saleha Sadeeqa, Tania Munawar
Abstract
Chronic kidney disorder is the progressive, irreversible damage to the kidney functions, as a result of which the renal replacement therapy is given in the form of dialysis (haemodialysis or peritoneal dialysis )and renal transplantation depending upon the patient condition, along with the medication therapy and lifestyle modifications. The focus of this study is to check the pharmaceutical care given to the patient of Chronic kidney disease on heamodialysis and the compliance of the patient to the therapy. The outcome of the therapy was to improve the patient’s quality of life, slow down the progression of the disease and to avoid the complications associated with the therapy.
Keywords: Chronic kidney disease (CKD), Haemodialysis, Pharmaceutical care, Quality of life.
